Monthira Suntiparpluacha
Overview
Explore the profile of Monthira Suntiparpluacha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Venkatraman S, Balasubramanian B, Kongpracha P, Yangngam S, Chuangchot N, Khanaruksombat S, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766097
Background: Cancer immune evasion is a multifaceted process that synchronizes pro-tumoral immune infiltration, immunosuppressive inflammation, and inhibitory immune checkpoint expression (IC). Current immunotherapies combat this issue by reinstating immunosurveillance of...
2.
Urumarudappa S, Tran V, Oo H, Suntiparpluacha M, Sampattavanich S, Rosa V, et al.
J Oral Pathol Med
. 2023 Sep;
52(10):939-950.
PMID: 37756121
Background: Mucoepidermoid carcinoma is a rare salivary gland malignant tumour. This study aimed to investigate inflammatory and immune signatures of mucoepidermoid carcinoma by identifying potential proteo-transcriptomic biomarkers towards the development...
3.
Suntiparpluacha M, Chanthercrob J, Sa-Nguanraksa D, Sitthikornpaiboon J, Chaiboonchoe A, Kueanjinda P, et al.
PeerJ
. 2023 Jun;
11:e15350.
PMID: 37334114
Background: Triple-negative breast cancer (TNBC) is a rare and aggressive breast cancer subtype. Unlike the estrogen receptor-positive subtype, whose recurrence risk can be predicted by gene expression-based signature, TNBC is...
4.
Prasopporn S, Suppramote O, Ponvilawan B, Jamyuang C, Chanthercrob J, Chaiboonchoe A, et al.
Front Oncol
. 2023 Jan;
12:1124912.
PMID: 36686801
[This corrects the article DOI: 10.3389/fonc.2022.1021632.].
5.
Prasopporn S, Suppramote O, Ponvilawan B, Jamyuang C, Chanthercrob J, Chaiboonchoe A, et al.
Front Oncol
. 2022 Dec;
12:1021632.
PMID: 36531039
Cholangiocarcinoma (CCA) is a highly lethal gastrointestinal malignancy that has one of the worst prognoses among solid tumors. The combination of Gemcitabine + Cisplatin (GEM/CIS) remains the standard first-line treatment...
6.
Suppramote O, Prasopporn S, Aroonpruksakul S, Ponvilawan B, Makjaroen J, Suntiparpluacha M, et al.
Front Oncol
. 2022 Jun;
12:877194.
PMID: 35664774
Cholangiocarcinoma (CCA) is one of the most difficult to treat cancers, and its nature of being largely refractory to most, if not all, current treatments results in generally poor prognosis...
7.
Sittithumcharee G, Suppramote O, Vaeteewoottacharn K, Sirisuksakun C, Jamnongsong S, Laphanuwat P, et al.
Hepatology
. 2019 May;
70(5):1614-1630.
PMID: 31077409
Cholangiocarcinoma (CCA) is a bile duct cancer with a very poor prognosis. Currently, there is no effective pharmacological treatment available for it. We showed that CCA ubiquitously relies on cyclin-dependent...
8.
Sa-Nguanraksa D, Suntiparpluacha M, Kulprom A, Kummalue T, Chuangsuwanich T, Avirutnan P, et al.
Asian Pac J Cancer Prev
. 2016 Jul;
17(6):2935-40.
PMID: 27356714
Breast cancer is the most frequent type of cancer diagnosed among women worldwide and also in Thailand. Estrogen and estrogen receptors exert important roles in its genesis and progression. Several...